Repeated treatment with psychostimulant drugs causes longlasting behavioral sensitization and associated neuroadaptations. Although sensitization induced by a single psychostimulant exposure has also been reported, information on the behavioral and neurochemical consequences of a single psychostimulant exposure is sparse. Therefore, to evaluate whether behavioral sensitization evoked by single and repeated psychostimulant pretreatment regimens represent the same neurobiological phenomenon, the time-dependent expression of behavioral, neurochemical, and neuroendocrine sensitization after a single exposure to amphetamine was investigated in rats. A single exposure to amphetamine (5 mg/kg, i.p.) caused context-independent sensitization of the locomotor effects of amphetamine, which intensified over time. Thus, sensitization to amphetamine was marginal at 3 d after treatment and more evident after 1 week, whereas 3 weeks after treatment, profound sensitization, as well as cross-sensitization, to cocaine was observed. Amphetamine pretreatment caused an increase in the electrically evoked release of [ 3 H]dopamine from nucleus accumbens, caudate putamen, and medial prefrontal cortex slices and of [ 14 C]acetylcholine from accumbens and caudate slices. The hyperreactivity of dopaminergic nerve terminals appeared to parallel the development of locomotor sensitization, i.e., whereas hyperreactivity of accumbens dopaminergic terminals increased between 3 d and 3 weeks after treatment, the hyperreactivity of medial prefrontal dopaminergic terminals decreased. Pre-exposure to amphetamine also sensitized the hypothalamus-pituitary-adrenal axis response to amphetamine at 1 and 3 weeks, but not at 3 d after treatment. Because these data closely resemble those reported previously for repeated amphetamine pretreatment, it is concluded that a single exposure to amphetamine is sufficient to induce long-term behavioral, neurochemical, and neuroendocrine sensitization in rats.
Repeated exposure to drugs of abuse results in a progressive and enduring enhancement of their psychomotor and positive reinforcing effects. This phenomenon, termed behavioral sensitization (Stewart and Badiani, 1993) , is thought to underlie certain aspects of drug addiction and drug-induced psychosis (Robinson and Becker, 1986; Robinson and Berridge, 1993; De Vries et al., 1998) . The expression of behavioral sensitization relies on timedependent neuroplastic changes in the brain circuitry involved in motivational behavior. Of the numerous neuroadaptive phenomena involved, long-lasting hyperreactivity of the mesolimbic dopaminergic pathway has received most attention (for review, see Pierce and Kalivas, 1997) .
The extent to which sensitization is induced by drug preexposure is highly dependent on the nature of the pretreatment regimen. Thus, repeated intermittent treatment with moderate doses of drugs is far more effective in inducing sensitization than chronic exposure to high or escalating drug doses (Post, 1980; Robinson and Becker, 1986; Stewart and Badiani, 1993; Vanderschuren et al., 1997) . Interestingly, next to repeated intermittent and chronic administration schedules, which both use multiple drug exposures, even a single exposure to amphetamine or cocaine has been found to induce behavioral and neurochemical sensitization (Robinson et al., 1982; Robinson, 1984; Peris and Zahniser, 1987; Kalivas and Alesdatter, 1993) . However, it is not clear whether sensitization induced by single and repeated psychostimulant exposure represents the same neurobiological phenomenon. For example, whereas there is a wealth of data on the neuroadaptive consequences of repeated psychostimulant treatment (for review, see White et al., 1995; Pierce and Kalivas, 1997; Wolf, 1998) , information on the neuroadaptive effects of a single psychostimulant exposure is sparse (Robinson et al., 1982; Peris and Zahniser, 1987) . Furthermore, repeated psychostimulant treatment can induce behavioral sensitization in both a contextdependent and a context-independent manner (Stewart and Druhan, 1993; Anagnostaras and Robinson, 1996; Robinson et al., 1998; Vanderschuren et al., 1999a) . However, sensitization after a single drug pretreatment has only been investigated in a contextdependent manner, meaning that tests for sensitization were performed in the same environment in which pretreatment took place, allowing for association of environmental cues with drug effects. In view of the differences between context-dependent and context-independent behavioral sensitization, both behaviorally (Anagnostaras and Robinson, 1996; Robinson et al., 1998) and neurobiologically (Hoffman and Wise, 1992; Li et al., 1997; Mead and Stephens, 1998) , it is of interest to investigate whether context-independent sensitization also occurs after a single psychostimulant exposure.
For these reasons, we evaluated the time-dependent behavioral, neurochemical, and neuroendocrine effects of a single exposure to amphetamine (5 mg / kg, I P) and compared them with the effects observed previously after repeated amphetamine treatment. Thus, the time course of amphetamine-induced contextindependent sensitization to the locomotor effects of amphetamine, as well as long-term cross-sensitization to cocaine and direct dopamine receptor agonists, was investigated. In addition, at various post-treatment intervals, we investigated the effect of amphetamine pre-exposure on the electrically evoked release of [ 3 H]dopamine and [ 14 C]acetylcholine from slices of nucleus accumbens, caudate putamen, and medial prefrontal cortex and on the secretion of AC TH and corticosterone elicited by a challenge with amphetamine.
MATERIALS AND METHODS
Animals and amphetamine pretreatment. All experiments were approved by the Animal C are Committee of the Free University of Amsterdam. Male Wistar rats (Harlan C PB, Z eist, The Netherlands), weighing 180 -200 gm at the time of amphetamine or saline pretreatment, were housed two per cage in Macrolon cages under controlled conditions (lights on from 7:00 A.M. to 7:00 P.M.). Animals were allowed to accustom to the housing conditions for at least 1 week before use. Food and water were available ad libitum. Animals were briefly handled on the 2 d preceding pretreatment and on the 2 d preceding subsequent drug challenges. Pretreatment consisted of a single injection with amphetamine (5 mg / kg, i.p.) or saline (1 ml / kg, i.p.), administered in the home cage. Amphetamine was dissolved in sterile saline.
Determination of locomotor activit y. Horizontal motor activity was measured in perspex cages (40 ϫ 40 ϫ 35 cm) using a video tracking system (EthoVision; Noldus Information Technology B.V., Wageningen, The Netherlands), which determined the position of the animal five times per second. E xperiments were started at approximately 9:30 A.M. White-noise was used to minimize the influence of surrounding sounds. L ocomotor challenge tests were conducted as follows. Animals were allowed to habituate to the test cages for 2 hr, during which activity was monitored. Then, animals received an injection with saline (1.0 ml / kg, s.c. or i.p., depending on the route of administration of the challenge drug), and activity was monitored for 1 hr. Subsequently, animals were injected with amphetamine (1 mg / kg, i.p.), cocaine (15 mg / kg, i.p.), the dopamine D1 receptor agonist SK F-82958 (1 mg / kg, s.c.), the dopamine D2 receptor agonist quinpirole (0.5 mg / kg, s.c.), or the nonselective dopamine agonist apomorphine (0.3 mg / kg, s.c.). To examine the time course of amphetamine sensitization, locomotor challenges with amphetamine were performed 3 d, 1 week, or 3 weeks after treatment. To examine the occurrence of long-term cross-sensitization to cocaine, SK F-82958, quinpirole, and apomorphine, locomotor challenges with these drugs were performed 3 weeks after treatment. The challenge doses of the drugs represent the doses used previously to investigate dopaminergic mechanisms involved in the expression of locomotor sensitization induced by repeated amphetamine treatment (Vanderschuren et al., 1999a) . Animals were challenged only once. All drugs were dissolved in sterile saline.
Determination of neurotransmitter release. Three days or 3 weeks after treatment, rats pre-exposed to saline or amphetamine were decapitated, and nucleus accumbens, caudate putamen, and medial prefrontal cortex were rapidly dissected. Tissue slices (0.3 ϫ 0.3 ϫ 1 mm) were prepared using a McI lwain tissue chopper and superf used as described previously Nestby et al., 1997) . Slices (pooled tissue of two to three rats) were washed twice with Krebs'-Ringer's bicarbonate medium containing (in mM) 121 NaC l, 1.87 KC l, 1.17 K H 2 PO 4 , 1.17 MgSO 4 , 1.22 C aC l 2 , 25 NaHC O 3 , and 10 D-(ϩ)-glucose, and subsequently incubated for 15 min in this medium under a constant atmosphere of 95% O 2 -5% C O 2 at 37°C. After preincubation, the slices were rapidly washed and incubated for 15 min in 2.5 ml of medium containing 5 Ci [ 3 H]dopamine and 2 Ci [ 14 C]choline, under an atmosphere of 95% O 2 -5% C O 2 at 37°C. Because the nucleus accumbens and medial prefrontal cortex have a dense noradrenergic innervation, 3 M desipramine was added during incubation to prevent accumulation of [ 3 H]dopamine in noradrenergic nerve terminals. After labeling, the slices were rapidly washed and transferred to each of 24 chambers of a superf usion apparatus (ϳ4 mg of tissue in 0.2 ml volume per chamber) and superf used (0.20 ml /min) with medium gassed with 95% O 2 -5% C O 2 at 37°C.
In each experiment, neurotransmitter release from slices of saline-and amphetamine-pretreated rats was studied simultaneously in 24 parallel superf usion chambers. The superf usate was collected as 10 min samples after 40 min of superf usion (t ϭ 40 min). C a 2ϩ -dependent neurotransmitter release was induced during superf usion by exposing the slices to electrical biphasic block pulses (1 Hz, 30 mA, 2 msec pulses for nucleus accumbens and caudate putamen slices; and 1 Hz, 15 mA, 2 msec pulses for medial prefrontal cortex slices) for 10 min at t ϭ 50 min (electrical field stimulation).
The radioactivity remaining at the end of the experiment was extracted from the tissue with 0.1 N HC l. The radioactivity in superf usion fractions and tissue extracts was determined by liquid scintillation counting. The efflux of radioactivity during each collection period was expressed as a percentage of the amount of radioactivity in the slices at the beginning of the respective collection period. The electrically evoked release of neurotransmitter was calculated by subtracting the spontaneous efflux of radioactivity from the total overflow of radioactivity during stimulation and the next 10 min. A linear decline from the 10 min interval before to that 20 -30 min after the start of stimulation was assumed for calculation of the spontaneous efflux of radioactivity. The release evoked was expressed as percentage of the content of radioactivity of the slices at the start of the stimulation period.
Determination of hypothalamus-pituitar y -adrenal a xis activit y. After a post-treatment interval of 3 d, 1 week, or 3 weeks, saline-or amphetamine-pretreated rats were injected with amphetamine (1 mg / kg, i.p.), placed back into their home cages, and decapitated 20 min later. Trunk blood was collected in ice-cold heparin-coated tubes and centrif ugated (1000 ϫ g, 15 min, 4°C). Aliquots of plasma were stored at Ϫ20°C until assayed. AC TH concentrations were measured as described previously (Van Oers et al., 1992) using antiserum 8514 against the midportion of AC TH (Kovacs and Makara, 1988) . Synthetic rat AC TH was used as a standard. The sensitivity of the assay was 10 pg /ml plasma (0.5 pg / tube). Plasma AC TH concentrations were expressed as pg /ml plasma. Plasma corticosterone levels were determined by radioimmunoassay (IC N Biochemicals, Costa Mesa, CA) and expressed as nanograms per milliliter plasma. The sensitivity of the assay was 0.7 ng /ml plasma.
Radiochemicals and drugs. Statistics. Horizontal locomotor activity, expressed as distance traveled (in centimeters) was calculated in 10 min blocks. L ocomotor activity was analyzed using two-factor repeated-measures ANOVA for time block and pretreatment. Post hoc comparisons were performed using StudentNewman -Keuls tests. In vitro neurotransmitter release and plasma AC TH and corticosterone concentrations were calculated as percentage of values from saline-pretreated rats in the respective experiment. Observations of different experiments were pooled and analyzed using one-way ANOVA.
RESULTS

Time-dependent locomotor sensitization to amphetamine
The locomotor effects of amphetamine (1 mg/kg, i.p.) in salineand amphetamine-pretreated rats after various post-treatment intervals are presented in Figure 1 A-C. The locomotor effect of amphetamine was enhanced in rats pre-exposed to amphetamine at 3 d, 1 week, and 3 weeks after treatment, but to a different degree. Three days after exposure, the locomotor effects of amphetamine were only marginally affected by amphetamine pretreatment (pretreatment, F (1,44) ϭ 0.04; NS; pretreatment ϫ time, F (8,352) ϭ 3.29; p Ͻ 0.01), sensitization being evident during the second 10 min time block only (Fig. 1 A) . One week after treatment, a more marked amphetamine pretreatment effect was found (pretreatment, F (1,30) ϭ 3.45; p ϭ 0.07;) pretreatment ϫ time, F (8,240) ϭ 3.82; p Ͻ 0.0001). In amphetamine-pre-exposed rats, the locomotor effects of amphetamine were enhanced during the first three 10 min time blocks (Fig. 1 B) . A clear-cut sensitization of the locomotor effects of amphetamine in amphetaminepre-exposed animals was observed 3 weeks after treatment (pretreatment, F (1,27) ϭ 11.48; p Ͻ 0.01; pretreatment ϫ time, F (8,216) ϭ 2.58; p Ͻ 0.05). Post hoc analysis showed a significant enhancement of amphetamine-induced hyperlocomotion during the first six 10 min time blocks (Fig. 1C) . Pretreatment with amphetamine did not result in altered locomotion during the habituation phases (data not shown) and the challenges with saline, irrespective of the post-treatment interval at which testing was performed ( Fig. 1 A-C) .
Long-term cross-sensitization to cocaine and dopamine receptor agonists
The long-term effects of a single pre-exposure to 5 mg/kg amphetamine on locomotor activity induced by cocaine and dopamine receptor agonists are presented in Figure 2 . Three weeks after treatment, amphetamine-pre-exposed rats were sensitized to the locomotor effects of cocaine (15 mg/kg, i.p.) (pretreatment, F (1,13) ϭ 4.49; p ϭ 0.05; pretreatment ϫ time, F (8,104) ϭ 2.41; p Ͻ 0.05). Post hoc analysis revealed a significant enhancement of the locomotor effect of cocaine during three 10 min time blocks (Fig.  2 A) . In animals pretreated with amphetamine, the locomotor effect of the D1 receptor agonist SKF-82958 was altered. The overall locomotor effect of SKF-82958 appeared not to be affected at all by amphetamine pretreatment (total distance traveled, 14053 Ϯ 2919 cm in saline-pre-exposed rats and 13794 Ϯ 3223 cm in amphetamine-pre-exposed rats; pretreatment, F (1,30) ϭ 0.00; NS). However, the time course of SKF-82958 locomotion was altered in amphetamine-pre-exposed animals (pretreatment ϫ time, F (14,420) ϭ 3.48; p Ͻ 0.0001); post hoc tests revealed a significant increase in the locomotor effect of SKF-82958 in amphetamine-pretreated rats during the first two 10 min time blocks (Fig. 2 B) . When saline-and amphetamine-pretreated rats were challenged with the D2 receptor agonist quinpirole, a tendency toward sensitization in amphetamine-pretreated rats was found (pretreatment, F (1,12) ϭ 4.24; p ϭ 0.06; pretreatment ϫ time, F (23,276) ϭ 0.85; NS) (Fig. 2C) . The locomotor effects of the nonselective dopamine receptor agonist apomorphine did not differ between rats pretreated with saline and amphetamine (pretreatment, F (1,14) ϭ 0.36; NS; pretreatment ϫ time, F (8,112) ϭ 1.81; NS) (Fig. 2 D) . Amphetamine pre-exposure did not result in altered locomotion during the habituation phases (data not shown) and the challenges with saline ( Fig. 2 A-D) . 14 C]acetylcholine release data from medial prefrontal cortex slices are not presented.
Time-dependent adaptive changes in forebrain dopamine and acetylcholine neurotransmission
As shown in Figure 3 , the responsiveness of all types of nerve terminals investigated was increased at both time points as a 1 week ( B) , or 3 weeks ( C) after treatment. After 2 hr habituation to the test cages, the animals were injected with saline (1 ml / kg, i.p.) and 1 hr later with amphetamine, after which activity was monitored for 1.5 hr. Data are expressed as mean Ϯ SEM traveled distance (in centimeters) per 10 min interval. *p Ͻ 0.05, different from saline-pretreated rats (Student-Newman -Keuls).
consequence of amphetamine pretreatment. In nucleus accumbens slices, the amphetamine-induced hyperreactivity of dopaminergic nerve terminals increased over time (3 d vs 3 weeks, F (1,76) ϭ 4.41; p Ͻ 0.05), from a 41% increase 3 d (F (1,63) ϭ 12.35; p Ͻ 0.001) to a 69% increase 3 weeks (F (1,83) ϭ 39.31; p Ͻ 0.0001) after treatment. On the other hand, the responsiveness of cholinergic nerve terminals in nucleus accumbens slices as a result of pretreatment with amphetamine was enhanced to a similar degree at both time points: 39% at 3 d (F (1,65) ϭ 12.21; p Ͻ 0.001) and 41% at 3 weeks (F (1,85) ϭ 32.64; p Ͻ 0.0001) after treatment (Fig. 3A) . The neuroadaptive effects of amphetaminepretreatment observed in caudate putamen were comparable but smaller than those found in the accumbens. The hyperresponsiveness of dopaminergic nerve terminals increased, from an enhancement of 20% at 3 d (F (1,58) ϭ 6.97; p Ͻ 0.05) to 34% at 3 weeks (F (1,55) ϭ 16.50; p Ͻ 0.001) after treatment, but this time effect was not significant (3 d vs 3 weeks, F (1,56) ϭ 2.11; NS). Amphetamine-induced hyperreactivity of cholinergic nerve terminals in caudate putamen slices was comparable at both time points: 37% at 3 d (F (1,55) ϭ 16.82; p Ͻ 0.001) and 34% at 3 weeks (F (1,66) ϭ 12.67; p Ͻ 0.001) after treatment (Fig. 3B) . With regard to hyperresponsiveness of dopaminergic nerve terminals in medial prefrontal cortex slices, a picture opposite from that observed in accumbens and caudate slices emerged. As a result of preexposure to amphetamine, neuronal responsiveness was increased at 3 d after treatment by 78% (F (1,30) ϭ 38.14; p Ͻ 0.0001), and this effect significantly declined (3 d vs 3 weeks, F (1,37) ϭ 12.90; p Ͻ 0.01) to a 36% increase at 3 weeks after treatment (F (1,41) ϭ 24.01; p Ͻ 0.0001) (Fig. 3C) .
Time-dependent sensitization of the hypothalamus-pituitary-adrenal axis
The effects of amphetamine (1 mg/kg, i.p.) on plasma concentrations of ACTH and corticosterone in rats pretreated with saline or amphetamine are presented in Figure 4 , A and B, respectively. There was a considerable variation between experiments regarding the magnitude of neuroendocrine parameters determined. In saline-pretreated rats, amphetamine-induced plasma concentrations of ACTH varied between 51.7 Ϯ 9.4 and 148.4 Ϯ 11.0 pg/ml and plasma corticosterone between 43.3 Ϯ 5.4 and 121.2 Ϯ 15.1 ng/ml. Despite this variation, there were clear-cut effects of amphetamine pre-exposure on hypothalamus-pituitary-adrenal axis reactivity to amphetamine. Three days after treatment, no effect of amphetamine pre-exposure on the amphetamineinduced increase in the secretion of ACTH (F (1,8) ϭ 0.03; NS) (Fig. 4 A) and corticosterone (F (1,8) ϭ 0.21; NS) (Fig. 4 B) was observed. One week after treatment, the amphetamine-induced increase in both ACTH and corticosterone secretion were significantly augmented in amphetamine-pretreated rats; the secretion of ACTH was increased by 43% (F (1,9) ϭ 7.06; p Ͻ 0.05) (Fig. 4 A) and the secretion of corticosterone by 84% (F (1,8) ϭ 8.31; p Ͻ 0.05) (Fig. 4 B) . Comparable effects were observed at 3 weeks after treatment, i.e., in animals pretreated with amphetamine, amphetamine-induced ACTH concentrations were increased by 34% (F (1,9) ϭ 5.50; p Ͻ 0.05) (Fig. 4 A) and corticosterone concentrations by 73% (F (1,11) ϭ 18.03; p Ͻ 0.01) (Fig. 4 B) .
DISCUSSION
The main finding in the present study is that a single exposure to amphetamine (5 mg/kg, i.p.) causes long-lasting behavioral sensitization associated with neurochemical and neuroendocrine adaptations. Amphetamine-induced behavioral sensitization was expressed in a context-independent manner and gradually developed after pretreatment, with sensitization being most pronounced at 3 weeks after treatment. Moreover, a long-lasting cross-sensitization to cocaine and a tendency toward crosssensitization to the dopamine D2 receptor agonist quinpirole was found after pre-exposure to amphetamine. Amphetamine pretreatment caused a time-dependent hyperreactivity toward depolarization of dopaminergic nerve terminals in the nucleus accumbens, caudate putamen, and medial prefrontal cortex and cholinergic nerve terminals in nucleus accumbens and caudate putamen. In addition, a delayed hyperreactivity of the hypothalamus-pituitary -adrenal axis toward an amphetamine challenge was induced by amphetamine pretreatment. Together, the effects of a single exposure to amphetamine closely resemble those we Schmidt et al., 1999; Vanderschuren et al., 1999a,b) and others (for review, see Pierce and Kalivas, 1997) have found previously after repeated amphetamine pretreatment. We therefore conclude that a single exposure to amphetamine is sufficient to induce long-lasting behavioral, neurochemical, and neuroendocrine sensitization in rats.
Long-term behavioral sensitization evoked by a single psychostimulant exposure has been reported previously, but the present study is the first to show that this can occur in a contextindependent manner, meaning that pretreatment and challenge injections were administered in separate environments. In this respect, it is important to note that during neither habituation phases nor saline challenges locomotor activity differed between amphetamine-and saline-pretreated rats. This indicates that amphetamine pretreatment did not induce changes in basal or novelty-induced locomotion or a conditioned psychomotor response to the injection. Therefore, the observed locomotor sensitization most likely represents a nonassociative increase in the sensitivity to the locomotor effects of psychostimulant drugs, as a result of neuroadaptive changes induced by amphetamine pretreatment.
With regard to locomotor sensitization, the pattern of effects evoked by a single pre-exposure to amphetamine strikingly resembled that induced by repeated amphetamine pretreatment. Thus, the magnitude of amphetamine-induced sensitization to the locomotor effects of amphetamine gradually increased with prolonged withdrawal (i.e., between 3 d and 3 weeks after treatment), which has also been observed after repeated amphetamine pretreatment (Kolta et al., 1985; Paulson et al., 1991; Vanderschuren et al., 1999b) . In addition, just like repeated amphetamine pretreatment (Conway and Uretsky, 1982; Robinson, 1984; Kalivas and Weber, 1988; Vanderschuren et al., 1999a,b) , single amphetamine caused cross-sensitization to cocaine but not to morphine and apomorphine. Also, both regimens induced crosssensitization to quinpirole but to different degrees, i.e., a robust sensitization after repeated amphetamine (Ujike et al., 1990; Vanderschuren et al., 1999a) , whereas cross-sensitization to quinpirole after single amphetamine just failed to reach statistical significance. There was a slight difference between single and repeated amphetamine with regard to the onset of the locomotor response to SK F-82958, which appeared to be somewhat faster after single amphetamine but slower after repeated amphetamine (Vanderschuren et al., 1999a) . The reason for this discrepancy remains to be clarified.
Neuroadaptive changes in mesotelencephalic dopaminergic projections play a prominent role in the induction and expression of amphetamine sensitization. Whereas sensitization can be induced by microinjection of amphetamine into the ventral tegmental area, the cell body region of the mesolimbic dopaminergic system (Kalivas and Weber, 1988; Perugini and Vezina, 1994; Cador et al., 1995) , its expression is associated with timedependent adaptations in forebrain dopaminergic terminal areas, such as the nucleus accumbens and caudate putamen (Kolta et al., 1985; Robinson et al., 1988; Wolf et al., 1993; Paulson and Robinson, 1995) . Dopaminergic neurotransmission in nucleus accumbens and caudate putamen plays a critical role in the locomotor and stereotypic effects of psychostimulant drugs, respectively (Kelly et al., 1975; Pijnenburg et al., 1975; Sharp et al., 1987; Delfs et al., 1990) . Therefore, it is likely that hyperresponsiveness of striatal dopaminergic nerve terminals plays a major role in the expression of psychostimulant sensitization. Indeed, in particular, after extended post-treatment intervals (Ͼ1 week), there appears to be a close correlation between hyperreactivity of striatal dopaminergic neurotransmission and expression of behavioral sensitization. On the other hand, inconsistencies in the occurrence of these phenomena have been reported after short post-treatment intervals (for review, see Pierce and Kalivas, 1997) . In the present study, a single amphetamine exposure induced hyperreactivity toward electrical depolarization of dopaminergic nerve terminals in the nucleus accumbens and caudate putamen, an effect that increased between 3 d and 3 weeks after treatment. This is consistent with findings reported after repeated amphetamine pretreatment, using both in vitro and in vivo preparations (Kolta et al., 1985; Wolf et al., 1993; Paulson and Robinson, 1995; Nestby et al., 1997) . We observed a strong relationship between hyperreactivity of accumbens dopaminergic neurotransmission and expression of locomotor sensitization to amphetamine, in that both phenomena gradually intensified with prolonged withdrawal. On the other hand, at 3 d after treatment, accumbens dopaminergic nerve terminals were markedly hyperreactive, but locomotor sensitization to amphetamine was only marginal. A possible explanation for this could be that the expression of amphetamine sensitization depends on the balance between dopamine neurotransmission in the nucleus accumbens and medial prefrontal cortex. Thus, consistent with the effects of repeated amphetamine pretreatment (Stephans and Yamamoto, 1995 ; L. J. M. J. Vanderschuren, unpublished observations), we found that a single exposure to amphetamine resulted in an enduring hyperreactivity of medial prefrontal dopaminergic nerve terminals. Remarkably, however, hyperreactivity of medial prefrontal dopaminergic nerve terminals decreased with prolonged withdrawal, displaying an opposite time course to the hyperreactivity of accumbens dopaminergic terminals. Increased dopaminergic neurotransmission in the medial prefrontal cortex is known to inhibit accumbens dopaminergic neurotransmission, as well as psychostimulant-induced locomotion (L ouilot et al., 1989; Vezina et al., 1991) . It might therefore be that, especially after a short post-treatment interval, hypersensitivity of medial prefrontal dopaminergic terminals exerts an inhibitory influence on the expression of amphetamine sensitization. Previous behavioral and neurochemical studies (Banks and Gratton, 1995; Prasad et al., 1999) support such a modulatory role of mesocortical dopaminergic neurotransmission in the induction and expression of psychostimulant sensitization.
A single amphetamine exposure evoked enduring hyperreactivity of cholinergic nerve terminals in nucleus accumbens and caudate putamen, an effect that also occurred after repeated amphetamine pretreatment . Interestingly, an increase in striatal acetylcholine release has been reported to correlate with the expression of amphetamine sensitization (Bickerdike and Abercrombie, 1997). In addition, in striatal slices of morphine-sensitized rats, enhanced cholinergic neurotransmission increased dopamine release through activation of presynaptic muscarinic receptors (Schoffelmeer et al., 1995) . Because striatal dopamine release can be stimulated by activation of presynaptic muscarinic (Schoffelmeer et al., 1995; Smolders et al., 1997) and nicotinic (Rowell et al., 1987; Mifsud et al., 1989; Marshall et al., 1997) receptors, hyperreactivity of cholinergic neurons may contribute to the expression of behavioral sensitization through a sustained stimulatory effect on striatal dopaminergic neurotransmission. Furthermore, interactions between dopaminergic and cholinergic input into efferent striatal neurons (Di Chiara et al., 1994) could also contribute to the expression of behavioral sensitization.
The neuroendocrine consequences of a single exposure to amphetamine were also similar to those after repeated amphetamine, i.e., in amphetamine-pretreated animals a hypersecretion of ACTH and corticosterone was found after an amphetamine challenge 3 weeks but not 3 d after treatment (Schmidt et al., 1999; E. D. Schmidt, unpublished observations) . Long-lasting sensitization of the ACTH and corticosterone response to amphetamine may be involved in the autonomic and affective consequences of amphetamine exposure, but a crucial role in the expression of psychostimulant sensitization has been questioned (Badiani et al., 1995; Johnson et al., 1995; Prasad et al., 1996; Schmidt et al., 1999) . On the other hand, the glucocorticoid receptor antagonist mifepristone (RU486) blocked the expression of amphetamine sensitization (De Vries et al., 1996) . Also, glucocorticoid receptor activation enhances dopamine neurotransmission Piazza et al., 1996; Schoffelmeer et al., 1997) , whereas corticosterone may augment the locomotor effects of psychostimulant drugs (Cador et al., 1993; Marinelli et al., 1994 Marinelli et al., , 1997 ; but see Badiani et al., 1995) . Therefore, a facilitatory role for central corticosteroid receptors in the expression of amphetamine sensitization cannot be excluded.
Together, the present data suggest that a single exposure to amphetamine is sufficient to induce long-lasting sensitization at the behavioral, neurochemical, and neuroendocrine levels. Repeated exposure to drugs of abuse induces a complex pattern of time-dependent adaptations in a variety of transmitter systems and brain regions, ultimately resulting in long-lasting behavioral sensitization (for review, see White et al., 1995; Pierce and Kalivas, 1997; Wolf, 1998) . It has been hypothesized that this cascade of neuroadaptations is driven by phasic alterations in gene expression. Mechanistic similarities between behavioral sensitization and other forms of neuronal plasticity, such as long-term memory, have been suggested. For instance, just like long-term memory (Tully, 1998) , the induction of long-lasting behavioral sensitization requires novel protein synthesis (Karler et al., 1993; Shimosato and Saito, 1993; Sorg and Ulibarri, 1995) , structural changes at relevant synapses (Robinson and Kolb, 1997) , and is most effectively induced by intermittent stimulation (Post, 1980;  
